Nonsteroidal antiinflammatory drugs and group A streptococcal infection

Emerging Infectious Diseases

Volumn 12, Issue 8, 2006, Pages 1291-

  Aronoff, David M ^a,c   Mulla, Zuber D ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c 6323 MSRB III ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

CASE CONTROL STUDY; CHILD; HUMAN; NOTE; PRESCHOOL CHILD; RISK FACTOR; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; HUMANS; RISK FACTORS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 33750585125     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1208.051067     Document Type: Letter

References (5)

1. Factor SH, Levine OS, Harrison LH, Farley MM, McGeer A, Skoff T, et al. Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis. 2005;11:1062-6.
2. Stevens DL. Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis. 1995;21:977-80.
3. Aronoff DM, Bloch KC. Assessing the relationship between the use of nonsteroidal antiinflammatory drugs and necrotizing fasciitis caused by group A streptococcus. Medicine (Baltimore). 2003;82:225-35.
4. Signorello LB, McLaughlin JK, Lipworth L, Friis S, Sorensen HT, Blot WJ. Confounding by indication in epidemiologic studies of commonly used analgesics. Am J Ther. 2002;9:199-205.
5. Mulla ZD, Leaverton PE, Wiersma ST. Invasive group Astreptococcal infections in Florida. South Med J. 2003;96:968-73.